“Consider rescheduling or moving all activities inside,” the air quality alert for Wisconsin, including Kenosha said. The ...

Osimertinib sales rose16% to $6.58 billion in 2024, confirming the drug's status as the leading weapon against lung cancer. Investors were excited about a potential challenger.

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and challenges shaping SMMT's future.

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer By Annika Kim Constantino, CNBC • Published June 17, 2025 • Updated on June 17, 2025 at ...

AstraZeneca's Enhertu combo improved progression-free survival in HER2+ metastatic ... European Drug Regulator Approves AstraZeneca’s Two Flagship Cancer Drugs For Breast And Lung Cancer ...

Amgen's positive lung cancer data: The company's drug, Imdelltra, reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease had worsened after an ...

Johnson & Johnson has pulled ahead of rival AstraZeneca Plc in a race to dominate the blockbuster market for lung cancer treatment, but data from a forthcoming study could quickly shake up the ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. A bold new way to test cancer drugs started Monday in hundreds of hospitals around the U.S. In a medical version of speed ...